The Deal Register
Database › Equity financing › ZYUS Life Sciences Corporation Announces Closing of First Tranche of…

Equity financing

ZYUS Life Sciences Corporation Announces Closing of First Tranche of Unit Offering and Issuance of Warrants…

Lane
Equity financing
Announced
07 Nov 2025
Province
Saskatchewan
Industry
Healthcare & life sciences
Status
Announced
What the filing says
ZYUS Life Sciences Corporation (the " Company ") (TSXV: ZYUS ), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that it has closed a first tranche (the " First Tranche ") of a non-brokered private placement (the " Offering ") of up to 2,307,692 units (each a "Unit") at a price of $0.65 per Unit for gross proceeds of up to $1,500,000.
Terms stated
exercise price, price per security
Source

The terms are in the subscriber edition

This transaction carries 2 stated terms, with the value, unit and basis of each and the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe